Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer.
靶向 CDK2 通过驱动间变性甲状腺癌的衰老而使其对乐伐替尼产生易感性
期刊:Advanced Science
影响因子:14.1
doi:10.1002/advs.202413514
Ma Ben, Sang Youzhou, Du Xiaoxue, Zhang Yanzhi, Yin Min, Xu Weibo, Liu Wanlin, Lu Jiayi, Guan Qing, Wang Yunjun, Liao Tian, Wang Yuting, Xiang Jun, Shi Rongliang, Qu Ning, Ji Qinghai, Zhang Jiwei, Ji Dongmei, Wang Yu